David Tuller
Trial By Error: My Letter to Professor Chew-Graham about the Cost of MUS
By David Tuller
By David Tuller, DrPH In multiple venues, Professor Carolyn Chew-Graham of Keele University has misstated the reported cost of so-called "medically unexplained symptoms" to the NHS. Professor Roger Jones, editor of the British Journal of General Practice, recently corrected such a misstatement in a 2017 editorial written by Professor Chew-Graham ...
Trial By Error: FOI Response from Bristol about LP Study; Correction in BJGP about MUS
By David Tuller
By David Tuller, DrPH SAME-DAY UPDATE: I have sent the University of Bristol's FOI office a follow-up request. I cc'd Sue Paterson, the university's director of legal services. Here's what I wrote: Dear FOI Office (and Ms Paterson)-- I appreciate the response to my questions from the above-referenced request. That ...
Trial By Error: An Update about the Pediatric MUS Systematic Review
By David Tuller
By David Tuller, DrPH This week I raised concerns about a second systematic review that cited the dung heap known as the Lightning Process study, published by Archives of Disease in Childhood two years ago. This new review did not mention the paper's egregious deficiencies. After the appearance in April ...
Trial By Error: Another Review Mentions LP Study and Prompts More Letters
By David Tuller
By David Tuller, DrPH In recent weeks, I have tried to bring attention to the troubling fact that a major systematic review of pediatric CFS/ME (as the authors called the illness) cited Bristol University€™s Lightning Process study as evidence that the intervention was effective. Now another systematic review, this one ...
Trial By Error: Jennie Spotila’s Latest NIH Funding Fact-Check
By David Tuller
Note: On her blog, Occupy M.E., Jennie Spotila recently posted another one of her indispensable close readings of NIH spending figures. I am reposting this here with Jennie's permission. ********** Another NIH Funding Fact-Check In April, NIH finally published their funding numbers for ME/CFS research in 2018. That means it ...